Parker Waichman LLP

FDA Warns Blood Disorder Could Result from Taking Idhifa (Enasidenib)

FDA Warns Leukemia Patients that Blood Disorder Could Result from Taking Idhifa (Enasidenib) The U.S. Food and Drug Administration (FDA) issued an urgent warning to Leukemia patients prescribed Idhifa. The FDA communication released on November 29, 2018, indicates that Idhifa patients are at a higher risk of suffering from a blood disorder that could go […]

FDA Warns Leukemia Patients that Blood Disorder Could Result from Taking Idhifa (Enasidenib)

FDA Warns about Idhifa Blood DisorderThe U.S. Food and Drug Administration (FDA) issued an urgent warning to Leukemia patients prescribed Idhifa. The FDA communication released on November 29, 2018, indicates that Idhifa patients are at a higher risk of suffering from a blood disorder that could go undiagnosed by doctors.  The FDA warns that differentiation syndrome, or retinoic acid syndrome, can be fatal and symptoms must be treated immediately in cancer patients suffering from acute myeloid leukemia. The FDA suggests that early detection of the signs and symptoms of differentiation syndrome can save a patient’s life.

Parker Waichman LLP, a national plaintiff’s law firm, is currently accepting clients who personally or a member of their family suffered from differentiation syndrome while taking Idhifa for acute myeloid leukemia and there was a misdiagnosis, failure of diagnosis, or slow diagnosis that lead to increased health complications or death. Parker Waichman LLP’s Idhifa side effect attorneys have extensive experience bringing claims on behalf of clients against major drug manufacturers for failing to warn about the potential side effects caused by a drug or for having a defect in its manufacturing process that led to severe injury, illness, or death.

Failing to Diagnose Differentiation Syndrome Could Be Fatal

The FDA requires enasienib manufacturers to include in their literature a warning that differentiation syndrome is a possible side effect. In fact, information concerning differentiation syndrome must be included within the “boxed warning” on Idhifa’s label. The FDA clarified, however, that doctors were failing to diagnose differentiation syndrome in patients despite knowledge of Idhifa’s potential side effects. The failure to diagnose this medical condition can result in the patient becoming extremely ill and possibly dying. Accordingly, the FDA recommends that patients report symptoms of differentiation syndrome as soon as possible and physicians treat the illness aggressively.

Symptoms of Differentiation Syndrome

The symptoms of Differentiation syndrome vary and may present as an ordinary respiratory infection and are therefore easily confused with or concealed by another illness or infection. However, the FDA lists the most common symptoms of Differentiation Syndrome as:

  • A fever,
  • Severe shortness of breath accompanied by a cough. The patient’s shortness of breath could require the use of supplemental oxygen,
  • Swelling of the arms and legs, as well as around the groin, neck, and underarm areas,
  • Rapid and substantial weight gain of ten pounds or more in one week,
  • Pain that feels deep in the bones, and
  • Dizziness or loss of balance.

A person suffering from any one or a combination of these symptoms and who is taking Idhifa must see a doctor or go to an emergency room as soon as possible. The FDA notes that symptoms can occur as recent as ten days after the first infusion of Idhifa up to five months after.  Although the symptoms of differentiation syndrome appear to be primarily respiratory in nature, the cause of the syndrome may be found in myeloid cells in the patient’s blood that proliferate and then differentiate.

The FDA suggests that the proper way to treat differentiation syndrome is with a heavy dose of corticosteroid medication. According to the FDA, doctors should prescribe 10 mg every 12 hours while continuing with Idhifa unless the patient has been intubated for 48 hours.

The FDA is Well Aware of the Potential Problems with Idhifa

The FDA approved Idhifa for use in mid-2017 even though the agency continues to measure the efficacy and danger of the drug. The FDA indicated that five people died from differentiation syndrome between May 1, 2018, and July 31, 2018, while taking Idhifa from differentiation syndrome either on its own or as a complication associated with other medical conditions.

Justice is a Phone Call Away

Someone suffering from acute myeloid leukemia already has a difficult fight, and it should not be compounded by reckless drug makers who race drugs to market with the rubber stamp approval of the FDA. That is why Idhifa injury attorneys from Parker Waichman LLP are ready to fight for justice for you and your family. Call 1800-YOURLAWYER today to find out more.

Sources:
FDA Safety Announcement
UpToDate: Differentiation syndrome associated with the treatment of acute leukemia

 

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness , Value
Diane Volpe
3 years ago
5 Star Reviews 150
Michele Josama and Rhonda Ware we appreciate your courtesy, kindness and concern regarding the handling of our family's Estate. Again, thank you for your professionalism and help.
Ricky Mason
a month ago
5 Star Reviews 150
I have been very happy with Parker Waichman's help with my 9/11 claim. I called after seeing a commercial and the law firm sent an investigator to my home to help me sign up, it was very easy. My paralegal Christina Morace always called me to keep me updated and checked on me throughout the whole waiting process for my compensation. I am very happy with all of her help and I would definitely recommend this law firm to my friends and family. Thank you Christina and Parker Waichman!
Armando Henry
3 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038